ID: ALA502968

Max Phase: Preclinical

Molecular Formula: C35H25Cl2N5O8S2

Molecular Weight: 778.65

Molecule Type: Small molecule

Representations

Canonical SMILES:  N=C(Nc1ccc2ccc(S(=O)(=O)Nc3ccc(Cl)c(C(=O)O)c3)cc2c1)Nc1ccc2ccc(S(=O)(=O)Nc3ccc(Cl)c(C(=O)O)c3)cc2c1

Standard InChI:  InChI=1S/C35H25Cl2N5O8S2/c36-31-11-7-25(17-29(31)33(43)44)41-51(47,48)27-9-3-19-1-5-23(13-21(19)15-27)39-35(38)40-24-6-2-20-4-10-28(16-22(20)14-24)52(49,50)42-26-8-12-32(37)30(18-26)34(45)46/h1-18,41-42H,(H,43,44)(H,45,46)(H3,38,39,40)

Standard InChI Key:  KVVUGKNHDAQCOL-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 778.65

Molecular Weight (Monoisotopic): 777.0522

AlogP: 7.76

#Rotatable Bonds: 10

Polar Surface Area: 214.85

Molecular Species: ACID

HBA: 7

HBD: 7

#RO5 Violations: 3

HBA (Lipinski): 13

HBD (Lipinski): 7

#RO5 Violations (Lipinski): 4

CX Acidic pKa: 2.56

CX Basic pKa: 3.61

CX LogP: 5.49

CX LogD: -0.61

Aromatic Rings: 6

Heavy Atoms: 52

QED Weighted: 0.05

Np Likeness Score: -0.72

References

1. Lum RT, Cheng M, Cristobal CP, Goldfine ID, Evans JL, Keck JG, Macsata RW, Manchem VP, Matsumoto Y, Park SJ, Rao SS, Robinson L, Shi S, Spevak WR, Schow SR..  (2008)  Design, synthesis, and structure-activity relationships of novel insulin receptor tyrosine kinase activators.,  51  (19): [PMID:18788731] [10.1021/jm800600v]

Source

Source(1):

• Scientific Literature